Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Veterinario de OncoLink / Tumores
Supported by the Savannah and Barry French Poodle Memorial Fund
University of Pennsylvania School of Veterinary Medicine
Ultima Vez Modificado: 21 de agosto del 2005
Michael H. Goldschmidt, MSc, BVMS, MRCVS, Diplomate ACVP Professor and Head, Laboratory of Pathology and Toxicology Chief, Surgical Pathology Department of Pathobiology
Frances S. Shofer, PhD, Adjunct Associate Professor of Epidemiology and Biostatistics
Ceruminous glands: These are modified apocrine glands found in the external ear canal that produce a brown waxy material. The glands consist of a secretory component surrounded by myoepithelial cells, and a duct which opens directly onto the epidermal surface of the external ear canal.
Definition—Ceruminous gland adenoma: A simple benign tumor with differentiation to ceruminous secretory epithelium.
Definition—Complex and mixed ceruminous gland adenoma: Complex (compound) ceruminous tumors have proliferation of glandular and myoepithelial cells. Mixed ceruminous tumors show a metaplastic change of the myoepithelium to cartilage or bone.
It has been suggested that chronic inflammation of the ear canal predisposes the animal to neoplasms.
| Sex | N | Percent |
| Female | 58 | 18% (21%) |
| Female Spayed | 111 | 34% (33%) |
| Male | 82 | 26% (25%) |
| Male Castrated | 72 | 22% (21%) |
| ( Normal Population %) |
| Breeds at Increased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| Cocker Spaniel | 89 | <0.0001 | 8.2 | 6.4 | 10.4 |
| Shih Tzu | 20 | <0.0001 | 4.4 | 2.8 | 6.9 |
| Lhasa Apso | 14 | <0.0001 | 4.1 | 2.4 | 7.0 |
| Toy Poodle | 5 | 0.0099 | 4.0 | 1.6 | 9.6 |
| Dachshund | 10 | 0.0110 | 2.4 | 1.3 | 4.5 |
| Breeds at Decreased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| German Shepherd | 5 | 0.0165 | 0.36 | 0.15 | 0.88 |
| Golden Retriever | 6 | <0.0001 | 0.24 | 0.11 | 0.54 |
| Doberman Pinscher | 1 | 0.0020 | 0.11 | 0.02 | 0.77 |
| Boxer | 1 | 0.0014 | 0.10 | 0.01 | 0.74 |

The presenting signs of ceruminous gland tumors are similar to those of chronic otitis externa, as the tumor, particularly adenomas, may occlude the external ear canal. The dog may therefore present with signs of
Otoscopic examination of the ear canal will identify any underlying tumor. Exophytic pedunculated masses (may be smooth or ulcerated, soft or firm) are most often adenomas.
Ceruminous gland adenomas that are pedunculated rarely recur because of the ease of adequate surgical excision. Non-pedunculated ceruminous gland adenomas may be more difficult to adequately excise, and, are thus, more likely to recur.
Definition—Ceruminous gland carcinoma: A simple malignant tumor with differentiation to ceruminous epithelium.
Definition—Complex and mixed ceruminous gland carcinoma: Complex (compound) ceruminous tumors have malignant proliferation of glandular cells and an accompanying proliferation of myoepithelial cells. Mixed ceruminous tumors show a metaplastic change of the myoepithelium to cartilage or bone.
It has been suggested that chronic inflammation of the ear canal predisposes the animal to neoplasms. These tumors are more common in the dog than are complex and mixed apocrine gland tumors.
| Sex | N | Percent |
| Female | 30 | 13% (21%) |
| Female Spayed | 69 | 31% (33%) |
| Male | 68 | 30% (25%) |
| Male Castrated | 57 | 26% (21%) |
| ( Normal Population %) |
| Breeds at Increased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| Shih Tzu | 16 | <0.0001 | 5.2 | 3.1 | 8.6 |
| Cocker Spaniel | 39 | <0.0001 | 4.6 | 3.2 | 6.5 |
| Lhasa Apso | 8 | 0.0035 | 3.4 | 1.7 | 6.8 |
| English Springer Spaniel | 8 | 0.0270 | 2.3 | 1.1 | 4.7 |
| Breeds at Decreased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| Golden Retriever | 8 | 0.0370 | 0.48 | 0.24 | 0.97 |
| Doberman Pinscher | 1 | 0.0239 | 0.16 | 0.02 | 1.13 |
| Boxer | 1 | 0.0246 | 0.15 | 0.02 | 1.08 |

The changes noted on physical examination are as described for benign tumors above, but infiltrative, erosive and ulcerative growths are more likely to be carcinomas.
This tumor shares many of the histopathologic features of the ceruminous gland adenoma. Differences include:
Ceruminous gland carcinomas are infiltrative and destructive of the surrounding tissues, and may become metastatic to the parotid and mandibular lymph nodes.
Survivorship care can help cancer survivors live healthier, fuller lives after treatment. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

